Manager, Clinical Development
SERB
Summary
The Manager, Clinical Development is accountable for the overall operation of clinical studies including project planning, budget, resource management and contract research organization contact within the overall context of an approved clinical operational plan for the portfolio of products that are consistent with lifecycle program/company goals. The ideal candidate is to be based on the East Coast.
Job description
Principle Responsibilities
- Manage all aspects for company sponsored and investigator-initiated studies (IISs) according to the applicable company Standard Operating Procedures (SOPs) and ensure all managed processes are compliant with internal SOPs and external regulations.
- Ensure that assigned clinical research projects comply with the clinical protocol, the most recent requirements for Good Clinical Practice (GCP) and other applicable regulations.
- Supervise outsourced tasks and services and manage contractor relationships ensuring appropriate oversight of vendors is maintained.
- Drafting any necessary study documents such as synopsis, study protocols, informed consents and study plans as per company SOP’s.
- Prepare clinical study budget and manage clinical study to approved budget.
- Ensure that regulatory documents are obtained from study sites and that study files are set up and maintained in accordance with GCP and relevant SOPs.
- Update and Draft SOP’s as and when required.
- Work with legal and sites to negotiate contracts for IIS’s.
- Maintains current knowledge of FDA regulations, and GCP and ICH Guidelines for clinical research.
- Ensuring that all interactions and engagements are carried out with the highest ethical and professional standards and that all work is accomplished with quality and in accordance with BTG values.
- Carry out other reasonable additional tasks as required by the Line Manager to support the clinical functions.
Education and Experience
University degree in a health-related field with a minimum of three (3) years direct clinical trial experience in a CRO or research-related organization. Previous experience with in-vitro diagnostic studies would be beneficial. EU experience would be beneficial.
Skills and Attributes
- Ability to work confidently work independently and as part of a team.
- Knowledge of clinical research process from Phase I through regulatory submission.
- Strong communication skills (verbal and written) to express complex ideas.
- Experience in contract/timeline management preferred with excellent organizational and interpersonal skills.
- Positive attitude and ability to interact with all levels of staff to coordinate and execute study activities.
- Ability to manage multiple priorities within various clinical trials.
- Ability to reason independently for the purpose of assessing and recommending specific solutions in clinical settings.
- Ability to set baseline targets, track trends and implement mitigation plans.
- Understanding of basic data processing functions, including electronic data capture.
- Working knowledge of current ICH GCP guidelines.
Requirements
- University degree in a health-related field
- Minimum of three (3) years direct clinical trial experience in a CRO or research-related organization
- Knowledge of clinical research process from Phase I through regulatory submission
- Strong communication skills (verbal and written)
- Experience in contract/timeline management preferred
- Excellent organizational and interpersonal skills
- Ability to manage multiple priorities within various clinical trials
- Understanding of basic data processing functions, including electronic data capture
- Working knowledge of current ICH GCP guidelines
Benefits
- Vacation
- Personal time
- Sick time
- 15 Paid Company Holidays
- Medical, Dental & Vision
- Voluntary benefits
- Paid Parental Leave
- Tuition Assistance
- Discretionary Bonus Plan
- 401(k) matching
Company overview
SERB Pharmaceuticals is a global specialty pharmaceutical company with a distinguished 30-year history focused on rare diseases, rare emergencies, and CBRN (chemical, biological, radiological, and nuclear) preparedness. Originally founded in France as Société d'Études et de Recherches Biologiques, the company has evolved into an international leader providing essential medicines to healthcare providers in over 100 countries. SERB maintains the world's leading portfolio of antidotes and medical countermeasures, addressing critical unmet medical needs in emergency medicine and rare conditions. The company operates as a fully integrated pharmaceutical organization with capabilities spanning acquisition, development, manufacturing, and global distribution. With commercial presence across the US, Europe, and the Middle East, SERB serves healthcare systems, first responders, emergency preparedness agencies, and non-profit organizations. Their recent acquisition of Y-mAbs Therapeutics has strengthened their rare oncology portfolio, demonstrating their commitment to advancing treatments for rare and hard-to-treat cancers while maintaining their core focus on life-saving emergency medicines.